Search - tctmd.com

Displaying 521 - 540 of 1868

Sort: Relevancy | Date

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

News Daily News

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

Todd Neale

July 04, 2022

News Opinion CV Team Dispatch

July 2022 News Roundup

L.A. McKeown

July 01, 2022

News Features

As US Abortion Protections Are Lost, Cardiologists Brace for Impact

Todd Neale

June 24, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

Impact of Moderate Aortic Stenosis on Long-Term Clinical Outcomes: A Systematic Review and Meta-Analysis

Presenter: Augustin Coisne

June 09, 2022

Presentation TVT 2022

BNP levels predict major adverse cardiovascular events in patients with moderate aortic stenosis: implications for aortic valve replacement

Presenter: Shlok Sarin

June 09, 2022

Presentation TVT 2022

Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis

Presenter: Yasser Radwan

June 09, 2022

Presentation TVT 2022

CT Planning for Challenging TAVR Indications: Bicuspid, Preventing Coronary Obstruction, Valve-in-Valve

Presenter: Philipp Blanke

June 08, 2022

Presentation TVT 2022

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Presenter: Martin Leon

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Presenter: Tsuyoshi Kaneko

June 08, 2022

Presentation TVT 2022

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Presenter: Janarthanan Sathananthan

June 08, 2022

Presentation TVT 2022

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

Presenter: Haim Danenberg

June 08, 2022

Presentation TVT 2022

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Conference News EuroPCR 2022

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Yael L. Maxwell

May 27, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

Advertisement

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

July 2022 News Roundup

As US Abortion Protections Are Lost, Cardiologists Brace for Impact

Minorities, Poorer Patients Missing Out on Structural Heart Care

More Support for Single Antiplatelet Therapy After TAVI

Impact of Moderate Aortic Stenosis on Long-Term Clinical Outcomes: A Systematic Review and Meta-Analysis

BNP levels predict major adverse cardiovascular events in patients with moderate aortic stenosis: implications for aortic valve replacement

Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis

CT Planning for Challenging TAVR Indications: Bicuspid, Preventing Coronary Obstruction, Valve-in-Valve

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content